Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

4.830

-0.340 (-6.58%)

At close: Apr 3, 2025, 4:00 PM

4.910

+0.080 (1.66%)

After-hours: Apr 3, 2025, 8:00 PM EDT

Emergent BioSolutions Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	1,044	1,049	1,118	1,774	1,577	Upgrade
Revenue Growth (YoY)	-0.54%	-6.10%	-36.99%	12.45%	42.61%	Upgrade
Cost of Revenue	668.2	689.3	644.5	980.4	714.2	Upgrade
Gross Profit	375.4	360	473	793.2	863.1	Upgrade
Selling, General & Admin	298.7	356.7	339.5	348.7	304.1	Upgrade
Research & Development	63.8	105.8	182.9	-	-	Upgrade
Operating Expenses	427.6	528.1	582.3	407.2	363.9	Upgrade
Operating Income	-52.2	-168.1	-109.3	386	499.2	Upgrade
Interest Expense	-71	-87.9	-37.3	-34.5	-31.3	Upgrade
Other Non Operating Income (Expenses)	13.1	8.9	-11.7	-3.7	4.7	Upgrade
EBT Excluding Unusual Items	-110.1	-247.1	-158.3	347.8	472.6	Upgrade
Merger & Restructuring Charges	-55.9	-33.2	-51.4	-	-	Upgrade
Impairment of Goodwill	-	-218.2	-6.7	-41.7	-	Upgrade
Gain (Loss) on Sale of Assets	24.3	74.2	-	-	-	Upgrade
Asset Writedown	-	-306.7	-	-	-29	Upgrade
Other Unusual Items	-1.2	-0.2	-2.6	-2.9	-31.7	Upgrade
Pretax Income	-142.9	-731.2	-219	303.2	411.9	Upgrade
Income Tax Expense	47.7	29.3	-7.4	83.7	106.1	Upgrade
Earnings From Continuing Operations	-190.6	-760.5	-211.6	219.5	305.8	Upgrade
Net Income	-190.6	-760.5	-211.6	219.5	305.8	Upgrade
Net Income to Common	-190.6	-760.5	-211.6	219.5	305.8	Upgrade
Net Income Growth	-	-	-	-28.22%	461.10%	Upgrade
Shares Outstanding (Basic)	53	51	50	54	53	Upgrade
Shares Outstanding (Diluted)	53	51	50	54	54	Upgrade
Shares Change (YoY)	3.52%	2.20%	-7.39%	0.56%	2.67%	Upgrade
EPS (Basic)	-3.60	-14.85	-4.22	4.10	5.80	Upgrade
EPS (Diluted)	-3.60	-14.85	-4.22	4.06	5.68	Upgrade
EPS Growth	-	-	-	-28.52%	446.15%	Upgrade
Free Cash Flow	35.8	-257.9	-149.9	96.1	395	Upgrade
Free Cash Flow Per Share	0.68	-5.04	-2.99	1.78	7.34	Upgrade
Gross Margin	35.97%	34.31%	42.33%	44.72%	54.72%	Upgrade
Operating Margin	-5.00%	-16.02%	-9.78%	21.76%	31.65%	Upgrade
Profit Margin	-18.26%	-72.48%	-18.93%	12.38%	19.39%	Upgrade
Free Cash Flow Margin	3.43%	-24.58%	-13.41%	5.42%	25.04%	Upgrade
EBITDA	53.4	-47	15.7	504.2	609.2	Upgrade
EBITDA Margin	5.12%	-4.48%	1.41%	28.43%	38.62%	Upgrade
D&A For EBITDA	105.6	121.1	125	118.2	110	Upgrade
EBIT	-52.2	-168.1	-109.3	386	499.2	Upgrade
EBIT Margin	-5.00%	-16.02%	-9.78%	21.76%	31.65%	Upgrade
Effective Tax Rate	-	-	-	27.61%	25.76%	Upgrade
Revenue as Reported	1,044	1,049	1,118	1,774	1,577	Upgrade

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q